Stanford University

  • Stanford Medicine Office of Community Engagement
    -
    Stanford University

    "Precision health holds great potential for revolutionizing health disparities research and interventions through a better understanding of the complex interplay between biological, behavioral, environmental, and social factors that contribute to health inequalities and influence population health. But the goal of achieving equity in precision health will require addressing persistent scientific

  • Stanford Medicine Office of Community Engagement
    -
    Stanford University

    Join Stanford Medicine | Office of Community Engagement for a COVID-19 COMMUNITY TOWN HALL this Thursday, May 27th | 3:30-5:00 PM PDT What's on the horizon? Address Emerging Issues Around COVID-19 Vaccines for Children, Variants of the Virus, and Mask Guidelines Online Event | Register Today! Spanish Translation Available on Zoom Only FEATURED SPEAKERS • Yvonne (Bonnie) A. Maldonado, MD, FAAP

  • Stanford Center for Clinical and Translational Research (Spectrum)
    -
    Stanford University

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Francesca Stillitano, Ph.D., from the Icahn School of Medicine at Mount Sinai, will present her research "Modeling familial and acquired cardiomyopathies using next-generation human-based models." Modeling familial and acquired cardiomyopathies using next

  • Stanford Center for Clinical and Translational Research (Spectrum)
    -
    Stanford University

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Eliot Peyster, MD, MSc, from the University of Pennsylvania, will present his research “Computational Histologic Analysis for the Diagnosis of Heart Transplant Rejection.” Computational Histologic Analysis for the Diagnosis of Heart Transplant Rejection (4/14

  • Urea Cycle Disorders Consortium

    Urea cycle disorders (UCDs) are rare but devastating genetic conditions. In 2003, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. The UCDC is currently

  • Primary Immune Deficiency Treatment Consortium

    The Primary Immune Deficiency Treatment Consortium (PIDTC) was established in 2009 to study and define optimal treatments for rare genetic disorders of the immune system, collectively known as primary immunodeficiency diseases. The PIDTC includes 44 immunology and transplantation centers throughout the United States and Canada as well as six patient advocacy groups. In its first nine years, the

  • North American Mitochondrial Disease Consortium (NAMDC)

    Mitochondrial diseases affect approximately 1 in every 5,000 people. These diseases can cause muscle weakness, difficulty thinking, seizures, hearing and vision loss, digestive problems, learning disabilities, and organ failure. The North American Mitochondrial Disease Consortium (NAMDC) is a network of clinicians and researchers at 17 different clinical sites working to better understand

  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE)

    Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in

  • Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

    Leukodystrophies are a complex, often progressive group of disorders affecting the white matter of the brain due to the loss or absence of myelin, the lipid membrane that insulates axons in the central nervous system. Despite advances in the diagnosis of these disorders, they remain widely under-recognized, with unmet gaps in clinical care and curative therapeutics. The Global Leukodystrophy

  • Genetic Disorders of Mucociliary Clearance Consortium (GDMCC)

    The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) focuses on several inherited and acquired disorders that cause thickened, infected secretions to accumulate in the upper and lower airways. Its work is conducted at eight clinical research sites across the United States and Canada. During the past 15 years, the consortium has made numerous advances that profoundly changed clinical

  • Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (CPIC)

    The Congenital and Perinatal Infections Consortium (CPIC) is focused on reducing the morbidity and mortality of rare viral infections such as congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal viral sepsis caused by enteroviruses (EVs) and the related human parechoviruses (HPeVs). These infections have been grouped together because of their

  • Stanford Center for Clinical and Translational Research (Spectrum)
    -
    Stanford University
    This 10-session course introduces the basics of clinical research design, including biostatistics, design of diagnostic and predictive test studies, and required/desired elements of clinical trial protocols. Participants will also gain an understanding of the regulatory aspects of clinical research conduct and oversight, Good Clinical Practice (GCP), and ethical dimensions of clinical research
  • Stanford Medicine Office of Community Engagement
    -
    Stanford University

    Join Stanford Medicine Office of Community Engagement for the 6th Virtual Town Hall on the COVID-19 outbreak, focusing on Vaccine Clinical Trials. Topics will include: How do vaccine clinical trials work? What do we know about the current vaccine trials underway in the United States? How do we know if it’s safe to participate in a trial? Who can/should participate in vaccine trials? Perspectives

  • DSC_RDCRN
    Autism spectrum disorder (ASD) affects 1 in 59 children in the United States and is a major public health concern and challenge. The Developmental Synaptopathies Consortium (DSC) aims to explore the underlying causes of autism by focusing on three rare genetic disorders related to ASD, including Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Tumor Syndrome (PHTS) and Phelan-McDermid Syndrome
  • Community Town Hall Event
    -
    Stanford University
    Join Stanford School of Medicine’s Office of Community Engagement for a virtual Town Hall on the COVID-19 outbreak. A panel of health experts will: Provide trusted evidence and resources on the epidemiology and medical management of COVID-19 Discuss current recommendations for shelter-at-home and social distancing Share latest COVID-19 research efforts at Stanford Answer community submitted
  • Stanford University
    Recorded sessions from Fall 2017 and Spring 2018 Module 1 - The Science of Research Designing and Conducting Randomized Clinical Trials (RCTs) Designing and conducting Observational Studies Mixed Methods, Focus Groups & Qualitative Research Data Management and Collection Module 2 - The Conduct of Research Developing a Clinical Protocol Running a Trial Trial Closeout Module 3 - Research &